Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
Chemotherapeutic and cytotoxic drugs are widely used in the treatment of cancer. In spite of the improvements in the life quality of patients, their effectiveness is compromised by several disadvantages. This represents a demand for developing new effective strategies with focusing on tumor cells an...
Main Author: | Mohammad Hojjat-Farsangi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/15/8/13768 |
Similar Items
-
Mechanisms of acquired resistance to tyrosine kinase inhibitors
by: Yi-fan Chen, et al.
Published: (2011-12-01) -
Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization
by: Halil Ibrahim Onder, et al.
Published: (2014-04-01) -
Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
by: D. Samuel Metibemu, et al.
Published: (2019-12-01) -
Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
by: Kalpana K. Bhanumathy, et al.
Published: (2021-01-01) -
Tyrosine Kinase Receptors in Oncology
by: Jorge Esteban-Villarrubia, et al.
Published: (2020-11-01)